
Michael Patrick Guest
Price Movement Since Trade
How each stock has moved from the trade date to the most recent close.
Suspicious Timing Detected
3 flagsRep. Guest bought $1K-$15K in Amazon on Nov 8, 2024 — 90 days before the Growing and Preserving Innovation in America Act (HR1062) was introduced, a bill that would permanently lock in higher tax deductions for US multinationals like Amazon.
Rep. Guest bought $1K-$15K in Amazon on Nov 8, 2024 — 122 days before the American Innovation and R&D Competitiveness Act (HR1990) was introduced, a bill that would restore immediate R&D expensing and directly benefit Amazon's large R&D operations.
Rep. Guest bought $1K-$15K in Tesla on Nov 8, 2024 — 130 days before the Stop CARB Act (HR2218) was introduced, a bill that would eliminate California's emissions waiver and potentially boost Tesla's competitive position.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $AMZN | Amazon.com, Inc. - Common Stock (AMZN) [ST] | $1K-$15K | $208.18 | — | — | Nov 8, 2024 |
| BUY | $MNDY | monday.com Ltd. - Ordinary Shares (MNDY) [ST] | $1K-$15K | $324.31 | $65.87 | -79.7% | Nov 8, 2024 |
| BUY | $TSLA | Tesla, Inc. - Common Stock (TSLA) [ST] | $1K-$15K | $321.22 | — | — | Nov 8, 2024 |
Connected Legislative Activity
4 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Unplug the Electric Vehicle Charging Stations Program Act
H.R. 1513 targets $7.5 billion in federal EV charging grants for repeal. The bill is in early committee stage but has a companion Senate bill, increasing its probability of advancement. Pure-play charging companies EVgo, ChargePoint, and Blink face direct revenue risk from the loss of NEVI and CFI capital co-funding. Tesla faces indirect headwinds from slower EV adoption, though its proprietary Supercharger network and vehicle sales buffer the impact.
American Innovation and R&D Competitiveness Act of 2025
HR1990, the American Innovation and R&D Competitiveness Act, would restore immediate expensing for R&D costs, reversing the 2022 tax code change that required 5/15-year amortization. This is an early-stage bill referred to Ways and Means with 81 cosponsors, but if enacted, it would provide a direct 21% tax-rate cash flow benefit annually to every R&D-intensive US company. The largest absolute beneficiaries are mega-cap tech and pharma firms with $10B+ annual R&D budgets.
Stop CARB Act of 2025
The Stop CARB Act of 2025, introduced on March 18, 2025, and referred to the House Energy and Commerce Committee, would eliminate California's federal waiver to set independent vehicle emissions standards. This is structurally bullish for legacy automakers GM and Ford and integrated oil majors ExxonMobil and Chevron, which face reduced compliance costs and preserved ICE demand. It is structurally bearish for pure-play EV makers Tesla, Rivian, and Lucid, which lose a key regulatory tailwind and credit revenue streams. The bill is in early legislative stages with only 6 cosponsors and a companion bill in the Senate.
Growing and Preserving Innovation in America Act of 2025
HR1062 permanently locks in higher FDII and GILTI deductions for US multinationals, preventing a ~3.3 ppt effective tax rate increase on foreign IP income scheduled for 2026. This directly boosts after-tax net income for companies with large international revenue streams, including MSFT, AAPL, GOOGL, AMZN, NVDA, JNJ, PFE, KO, and PG. The bill is in early committee stage — structural impact is contingent on passage through the 119th Congress.
Other Filings by Michael Patrick Guest
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.